PortfoliosLab logoPortfoliosLab logo
DTIL vs. ONCT
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DTIL vs. ONCT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Precision BioSciences, Inc. (DTIL) and Oncternal Therapeutics, Inc. (ONCT). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period


DTIL

1D
-4.43%
1M
-20.84%
YTD
45.19%
6M
19.37%
1Y
17.28%
3Y*
-35.49%
5Y*
-55.07%
10Y*

ONCT

1D
0.00%
1M
0.00%
YTD
6M
1Y
3Y*
5Y*
10Y*
*Multi-year figures are annualized to reflect compound growth (CAGR)

DTIL vs. ONCT - Yearly Performance Comparison


Correlation

The correlation between DTIL and ONCT is -0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (All Time)
Calculated using the full available price history since Feb 9, 2026

-0.06

Fundamentals

Total Revenue (TTM)

DTIL:

$45.07M

ONCT:

$1.67M

Gross Profit (TTM)

DTIL:

$32.19M

ONCT:

-$16.96M

EBITDA (TTM)

DTIL:

-$30.02M

ONCT:

-$17.87M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DTIL vs. ONCT — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

DTIL
DTIL Risk / Return Rank: 4949
Overall Rank
DTIL Sharpe Ratio Rank: 5050
Sharpe Ratio Rank
DTIL Sortino Ratio Rank: 5151
Sortino Ratio Rank
DTIL Omega Ratio Rank: 4848
Omega Ratio Rank
DTIL Calmar Ratio Rank: 4848
Calmar Ratio Rank
DTIL Martin Ratio Rank: 4747
Martin Ratio Rank

ONCT
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

DTIL vs. ONCT - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Precision BioSciences, Inc. (DTIL) and Oncternal Therapeutics, Inc. (ONCT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


DTILONCTDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.10

Calmar ratioReturn relative to maximum drawdown

0.30

Martin ratioReturn relative to average drawdown

0.56

DTIL vs. ONCT - Sharpe Ratio Comparison


Loading charts...

Sharpe Ratios by Period


DTILONCTDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.25

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.70

Sharpe Ratio (All Time)

Calculated using the full available price history

-0.55

1.68

-2.23

Drawdowns

DTIL vs. ONCT - Drawdown Comparison

The maximum DTIL drawdown since its inception was -99.39%, which is greater than ONCT's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for DTIL and ONCT.


Loading charts...

Drawdown Indicators


DTILONCTDifference

Max Drawdown

Largest peak-to-trough decline

-99.39%

0.00%

-99.39%

Max Drawdown (1Y)

Largest decline over 1 year

-58.54%

Max Drawdown (3Y)

Largest decline over 3 years

-85.40%

Max Drawdown (5Y)

Largest decline over 5 years

-99.16%

Current Drawdown

Current decline from peak

-98.98%

0.00%

-98.98%

Average Drawdown

Average peak-to-trough decline

-77.65%

0.00%

-77.65%

Ulcer Index

Depth and duration of drawdowns from previous peaks

30.78%

Volatility

DTIL vs. ONCT - Volatility Comparison


Loading charts...

Volatility by Period


DTILONCTDifference

Volatility (1M)

Calculated over the trailing 1-month period

20.95%

Volatility (6M)

Calculated over the trailing 6-month period

49.88%

Volatility (1Y)

Calculated over the trailing 1-year period

68.81%

0.00%

+68.81%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

79.38%

0.00%

+79.38%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

84.87%

0.00%

+84.87%

Dividends

DTIL vs. ONCT - Dividend Comparison

Neither DTIL nor ONCT has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DTIL vs. ONCT - Financials Comparison

This section allows you to compare key financial metrics between Precision BioSciences, Inc. and Oncternal Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0010.00M20.00M30.00M40.00M50.00M60.00M70.00M20222023202420252026
10.84M
0
(DTIL) Total Revenue
(ONCT) Total Revenue
Values in USD except per share items

Frequently Asked Questions


DTIL and ONCT have a correlation of -0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for DTIL and ONCT

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer